Endarterectomy versus stenting for carotid stenosis [1]

New England Journal of Medicine

Volumn 356, Issue 3, 2007, Pages 305-307

  Bonvini, Robert F ^a   Righini, Marc ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; INTERMETHOD COMPARISON; LETTER; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKILL; STENT; TREATMENT FAILURE; REVASCULARIZATION; NOTE;

ANTITHROMBOCYTIC AGENT; HEPARIN; FIBRINOLYTIC AGENT;

CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; FIBRINOLYTIC AGENTS; HUMANS; STENTS;

EID: 33846449189     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc063228     Document Type: Letter

References (5)

1. Mas J-L, Chatellier G, Beyssen B, et al. Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;355:1660-71.
2. SPACE Collaborative Group. 30 Day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006;368:1239-47. [Erratum, Lancet 2006;368:1238.]
3. Reimers B, Sievert H, Schuler GC, et al. Proximal endovascular flow blockage for cerebral protection during carotid artery stenting: results from a prospective multicenter registry. J Endovasc Ther 2005;12:156-65.
4. Cremonesi A, Manetti R, Setacci F, Setacci C, Castriota F. Protected carotid stenting: clinical advantages and complications of embolic protection devices in 442 consecutive patients. Stroke 2003;34:1936-41.
5. Lin PH, Bush RL, Peden EK, et al. Carotid artery stenting with neuroprotection: assessing the learning curve and treatment outcome. Am J Surg 2005;190:850-7.